| Dr Jeffrey D Disney, MD | |
|
1001 Providence Dr, Dept Of Emergency Medicine, Newberg, OR 97132-7485 | |
| (503) 537-1785 | |
| Not Available |
| Full Name | Dr Jeffrey D Disney |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1001 Providence Dr, Newberg, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306840822 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD-23629 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey D Disney, MD 1001 Providence Dr, Dept Of Emergency Medicine, Newberg, OR 97132-7485 Ph: (503) 537-1785 | Dr Jeffrey D Disney, MD 1001 Providence Dr, Dept Of Emergency Medicine, Newberg, OR 97132-7485 Ph: (503) 537-1785 |
News Archive
At the request of the Chinese Ministry of Health, WHO is today sending the first members of an international team to help investigate the source of SARS cases recently reported in Beijing and the eastern province of Anhui. The team, which is expected to begin work on Wednesday, will include experts in epidemiology, virology, infection control, and laboratory biosafety.
Members of the media are invited to attend a press availability period at noon on Friday, December 18, 2009 that will follow a scientific meeting evaluating the safety of soy infant formula. An independent panel of 14 scientists will evaluate the most current research on soy infant formula to determine whether exposure to soy infant formula is a risk to human development.
Animal research has failed to benefit human health, wasted limited public research funds, misled clinicians, and harmed countless animals unnecessarily, finds a new report by PETA scientists Emily Trunnell, Ph.D., and Frances Cheng, Ph.D.
Dr. Nicole Onetto, Deputy Director and Chief Scientific Officer of the Ontario Institute for Cancer Research (OICR), today announced the launch of an innovative Phase III clinical trial that aims to determine whether multi-parametric magnetic resonance imaging (MRI) coupled with transrectal ultrasound (TRUS) guided biopsy (called fusion technology) can accurately identify men with prostate cancer who are at risk of developing aggressive disease.
Mylan N.V. and Mylan Inc. today announced the successful completion of the acquisition of Abbott Laboratories' non-U.S. developed markets specialty and branded generics business.
› Verified 2 days ago
Dr. Lawrence R. Litwer, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2880 Hayes St, Newberg, OR 97132 Phone: 503-537-9600 | |
Todd Doyle, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 N Providence Dr, Newberg, OR 97132 Phone: 503-537-1555 | |
Dr. Thomas Michael Johnson, M.D., PH.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1001 Providence Dr, Newberg, OR 97132 Phone: 503-537-1785 | |
Dr. Evangeline Sokol, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1001 Providence Dr, Providence Newberg Hospital, Emergency Dept, Newberg, OR 97132 Phone: 503-537-1785 | |
Brian Richard Duncan, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1001 Providence Dr, Newberg, OR 97132 Phone: 503-537-1785 | |
John Carhart Mitchell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1001 Providence Dr, Newberg, OR 97132 Phone: 503-537-1785 |